PreemptiveAI Clinical SDK

Measure Labs, Inc. (Dba Preemptiveai, Inc.) · K250233 · 2026-02-13

PreemptiveAI Clinical SDK is an AI-enabled medical device from Measure Labs, Inc. (Dba Preemptiveai, Inc.), listed by FDA (510(k), K250233) with a decision date of 2026-02-13. Review panel: Cardiovascular.

FDA submission numberK250233
Pathway510(k)
CompanyMeasure Labs, Inc. (Dba Preemptiveai, Inc.)
Review panel (specialty)Cardiovascular
FDA decision date2026-02-13
DecisionSubstantially Equivalent
Product codeDXH
ClassificationTransmitters And Receivers, Electrocardiograph, Telephone
Device class2
Regulation number870.2920
Review time (calendar days)382
Applicant countryUS

Official FDA database record · FDA AI-enabled device list

All Cardiovascular AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.